Erica Billig Rose
Biographic Data
| ID | 10014868 |
|---|---|
| NAME | Erica Billig Rose |
| GIVEN NAMES | Erica Billig |
| FAMILY NAME | Rose |
| SIGNATURE | ROSE E B |
| AFFILIATIONS | Response Biomedical (Canada) |
| ORCID | 0000-0001-7056-511X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Comparative evaluation of Sars-CoV-2 laboratory testing data sources for U.S. Covid-19 public health surveillance, 2020–2024
Introduction: SARS-CoV-2 laboratory testing data were collected by the U.S. Centers for Disease Control and Prevention for surveillance during the COVID-19 pandemic response. Understanding how these existing data correlate and diverge can help guide their use and interpretation. Method: We evaluated COVID-19 Electronic Laboratory Reporting (CELR), the National Respiratory and Enteric Virus Surveillance System (NREVSS), Increasing Community Access…
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with Covid-19 in a Multistate Health Care Systems Network — United States, March–June 2020
Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19-associated illness and tailoring public health messaging, interventions, and policy. During April 15-June 25, 2020, telephone interviews were conducted with a random sample of …
No prominent works on this page.
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with Covid-19 in a Multistate Health Care Systems Network — United States, March–June 2020
Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19-associated illness and tailoring public health messaging, interventions, and policy. During April 15-June 25, 2020, telephone interviews were conducted with a random sample of …
Comparative evaluation of Sars-CoV-2 laboratory testing data sources for U.S. Covid-19 public health surveillance, 2020–2024
Introduction: SARS-CoV-2 laboratory testing data were collected by the U.S. Centers for Disease Control and Prevention for surveillance during the COVID-19 pandemic response. Understanding how these existing data correlate and diverge can help guide their use and interpretation. Method: We evaluated COVID-19 Electronic Laboratory Reporting (CELR), the National Respiratory and Enteric Virus Surveillance System (NREVSS), Increasing Community Access…
Public health (2 works) · Categorization (1 works) · COVID-19 and Mental Health (1 works) · COVID-19 Clinical Research Studies (1 works) · COVID-19 epidemiological studies (1 works) · Data collection (1 works) · Data-Driven Disease Surveillance (1 works) · Disease control (1 works) · Environmental health (1 works) · Family medicine (1 works)